Genix Pharmaceuticals Corp (GENX.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 10/31
| 01-2018 | 10-2017 | 07-2017 | 04-2017 | 01-2017 | |
| Sales | 252 | 290 | 225 | 224 | 272 |
| Cost of Goods | 117 | 106 | 142 | 107 | 156 |
| Gross Profit | 135 | 183 | 83 | 118 | 115 |
| Operating Expenses | 118 | 333 | 134 | 168 | 130 |
| Operating Income | 16 | -149 | -51 | -50 | -15 |
| Interest Expense | 2 | N/A | 3 | 4 | 4 |
| Other Income | 3 | 28 | -2 | 16 | -8 |
| Pre-tax Income | 18 | -122 | -56 | -38 | -27 |
| Net Income Continuous | 18 | -122 | -56 | -38 | -27 |
| Net Income | $18 | $-122 | $-56 | $-38 | $-27 |
| EPS Basic Total Ops | 0.00 | -0.01 | 0.00 | 0.00 | 0.00 |
| EPS Basic Continuous Ops | 0.00 | -0.01 | 0.00 | 0.00 | 0.00 |
| EPS Diluted Total Ops | 0.00 | -0.01 | 0.00 | 0.00 | 0.00 |
| EPS Diluted Continuous Ops | 0.00 | -0.01 | 0.00 | 0.00 | 0.00 |
| EBITDA(a) | $29 | $-145 | $-43 | $-24 | $-12 |